(Q36309218)

English

Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels (English)

1 reference

Europe PubMed Central

13 August 2017

decision making

1 reference

based on heuristic

inferred from title

author name string

Marieke E van Velden

1

1 reference

Europe PubMed Central

13 August 2017

Johan L Severens

2

1 reference

Europe PubMed Central

13 August 2017

Annoesjka Novak

3

1 reference

Europe PubMed Central

13 August 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

13 August 2017

PharmacoEconomics

1 reference

Europe PubMed Central

13 August 2017

23

1 reference

Europe PubMed Central

13 August 2017

11

1 reference

Europe PubMed Central

13 August 2017

1075-1082

1 reference

Europe PubMed Central

13 August 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200523110-00002

0 references

Managed care pharmacy, socioeconomic assessments and drug adoption decisions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of pharmacoeconomic data in making hospital formulary decisions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The review process used by US health care plans to evaluate new medical technology for coverage

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of formal benefit/cost evaluations in health system decision making

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluations of drug therapy: attitudes of primary care prescribing advisers in Great Britain

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation in health care: the usefulness of research guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A survey of physician attitudes and practices concerning cost-effectiveness in patient care

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Technology coverage decisions by health care plans and considerations by medical directors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What constitutes evidence in hospital new drug decision making?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current trends in the use of pharmacoeconomics and outcomes research in europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation under managed competition: evidence from the U.K.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physicians' duties in an era of cost containment: advocacy or betrayal?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Priority setting for new technologies in medicine: qualitative case study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health care reform in six Central European countries. A focus on health economic requirements in the drug pricing and reimbursement processes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of pharmacoeconomics to formulary decision making in managed care organizations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of economic evaluation in health care: Australian decision makers' perceptions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using evidence in the development of local health policies. Some evidence from the United Kingdom

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of cost-effectiveness information on physicians' cancer screening recommendations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ontario's formulary committee: how recommendations are made.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of economic information on medical decision making in primary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Cost-effectiveness" estimates result in flawed decision-making in listing drugs for reimbursement.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The view from managed care pharmacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of economic considerations on clinical decisionmaking: the case of thrombolytic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of drugs and its potential uses in policy making

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Priority-setting decisions for new cancer drugs: a qualitative case study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Priority setting in a hospital drug formulary: a qualitative case study and evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health Authorities

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaco-economic information and its effect on prescriptions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200523110-00002

1 reference

Europe PubMed Central

13 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36309218&oldid=1983558034"